Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor

被引:62
|
作者
Hoyer, S [1 ]
Henneberg, N [1 ]
Knapp, S [1 ]
Lannert, H [1 ]
Martin, E [1 ]
机构
[1] UNIV HEIDELBERG,ANESTHESIOL CLIN,D-69120 HEIDELBERG,GERMANY
来源
关键词
D O I
10.1111/j.1749-6632.1996.tb34448.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Glucose metabolism is essential for brain function and structure. Glucose contributes to the formation of neurotransmitters and is normally the only source for energy formation. There is increasing evidence that brain glucose metabolism is under control of the neuronal insulin/insulin receptor signal transduction. The present data clearly show that intracerebroventricularly administered insulin exerts anabolic effects on cerebral glucose/energy metabolism (amplification of the neuronal insulin receptor complex) whereas cortisol (corticosterone) acts antagonistically (desensitization of the neuronal insulin receptor complex). It is also shown that short-term cortisol (corticosterone) enhanced energy turnover in temporoparietal cortex and hippocampus. In contrast, long-term cortisol (corticosterone) reduced energy turnover in both brain structures studied. This metabolic pattern is reminiscent of that found in very old age. Therefore, it is assumed that long-term cortisol accelerates the aging process in the brain and thus the risk for age-related disorders such as dementia.
引用
收藏
页码:374 / 379
页数:6
相关论文
共 50 条
  • [41] Glucose and glycogen metabolism in the brain of insulin resistant Goto-Kakizaki rats
    Soares, A. F.
    Nussbaum, S. S.
    Gruetter, R.
    Duarte, J. M. N.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 : 417 - 417
  • [42] Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling
    Samovski, Dmitri
    Dhule, Pallavi
    Pietka, Terri
    Jacome-Sosa, Miriam
    Penrose, Eric
    Son, Ni-Huiping
    Flynn, Charles Robb
    Shoghi, Kooresh I.
    Hyrc, Krzysztof L.
    Goldberg, Ira J.
    Gamazon, Eric R.
    Abumrad, Nada A.
    DIABETES, 2018, 67 (07) : 1272 - 1284
  • [43] Adenosine A1 receptor is dispensable for hepatocyte glucose metabolism and insulin sensitivity
    Jain, Shanu
    Barella, Luiz F.
    Wess, Juergen
    Reitman, Marc L.
    Jacobson, Kenneth A.
    BIOCHEMICAL PHARMACOLOGY, 2021, 192
  • [44] The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity
    Moan, A
    Hoieggen, A
    Seljeflot, I
    Risanger, T
    Arnesen, H
    Kjeldsen, SE
    JOURNAL OF HYPERTENSION, 1996, 14 (09) : 1093 - 1097
  • [45] INFLUENCE OF INSULIN SENSITIVE CNS GLUCOREGULATOR RECEPTOR ON HEPATIC GLUCOSE-METABOLISM
    SZABO, O
    SZABO, AJ
    CLINICAL RESEARCH, 1975, 23 (03): : A334 - A334
  • [46] Effect of insulin, glucose, and glucose and insulin on the rate of metabolism of ethyl alcohol
    Gregory, R
    Ewing, PL
    Duff-White, V
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1943, 54 (02): : 206 - 208
  • [47] Drosophila Adiponectin Receptor in Insulin Producing Cells Regulates Glucose and Lipid Metabolism by Controlling Insulin Secretion
    Kwak, Su-Jin
    Hong, Seung-Hyun
    Bajracharya, Rijan
    Yang, Se-Yeol
    Lee, Kyu-Sun
    Yu, Kweon
    PLOS ONE, 2013, 8 (07):
  • [48] Altered Insulin-Dependent Brain Glucose Metabolism During Obesity Depends On Specific Brain Areas
    Malbert, C.
    Bahri, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S317 - S318
  • [49] MUTATIONS IN THE CHANNEL DOMAIN ALTER DESENSITIZATION OF A NEURONAL NICOTINIC RECEPTOR
    REVAH, F
    BERTRAND, D
    GALZI, JL
    DEVILLERSTHIERY, A
    MULLE, C
    HUSSY, N
    BERTRAND, S
    BALLIVET, M
    CHANGEUX, JP
    NATURE, 1991, 353 (6347) : 846 - 849
  • [50] Glucose transporter 3 in neuronal glucose metabolism: Health and diseases
    Peng, Wuxue
    Tan, Changhong
    Mo, Lijuan
    Jiang, Jin
    Zhou, Wen
    Du, Juncong
    Zhou, Xuan
    Liu, Xi
    Chen, Lifen
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123